| Filed On | Filing |
|---|---|
| 25 Sep 2026 |
Form 4: Parker Braden C., Chief Commercial Officer
Gave up 29,323 shares to cover exercise price or tax ($149K) |
| 11 Aug 2026 | S-8 |
| 11 Aug 2026 | 10-Q |
| 24 Jul 2026 |
Form 4: Lutz Robert Matthew, Chief Fin. & Operating Officer
Received 35,000 shares as a grant or award · Granted 70,000 Stock Option (Right to Buy) |
| 22 Jun 2026 |
Form 4: Lowrance David L, Chief Financial Officer
Received 580,187 shares by exercise or conversion ($1.02M) · Gave up 185,659 shares to cover exercise price or tax ($1.02M) · Sold 394,528 shares ($2.24M) |
| 22 Jun 2026 | 144 |
| 08 Jun 2026 | 8-K: Departure/Election of Directors or Officers; Compensation; Amendments to Articles/Bylaws; Change in Fiscal Year +1 more |
| 12 May 2026 | 10-Q |
| 24 Apr 2026 | ARS |
| 24 Apr 2026 | DEFA14A |
| 24 Apr 2026 |
Proxy statement: annual meeting on June 4, 2026
CEO pay $4.8M, down 1.4% · say-on-pay vote |
| 10 Apr 2026 | PRE 14A |
| 20 Mar 2026 |
Form 4: Lowrance David L, Chief Financial Officer
Received 366,747 shares by exercise or conversion ($588K) · Gave up 116,760 shares to cover exercise price or tax ($588K) |
| 13 Mar 2026 | 8-K: Entry into a Material Definitive Agreement |
| 13 Mar 2026 | 10-K |
| 17 Feb 2026 | SCHEDULE 13G/A |
| 17 Feb 2026 |
Form 4: McCracken Joseph S, Director
Received 1,807 shares by exercise or conversion ($3.18K) |
| 17 Feb 2026 | SCHEDULE 13G/A |
| 13 Feb 2026 | SCHEDULE 13G/A |
| 13 Feb 2026 | SCHEDULE 13G/A |
Loading...
